Detalles de la búsqueda
1.
Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach.
Int J Mol Sci
; 25(7)2024 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38612443
2.
CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles.
Int J Mol Sci
; 25(3)2024 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38338867
3.
Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application.
Int J Mol Sci
; 24(6)2023 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36982236
4.
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.
Int J Mol Sci
; 23(18)2022 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36142281
5.
Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy.
Molecules
; 25(4)2020 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32075083
6.
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
Lancet Oncol
; 19(10): 1360-1371, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30217671
7.
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.
Mol Cancer
; 16(1): 86, 2017 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454547
8.
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.
Lancet Oncol
; 16(1): 98-107, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25498219
9.
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma.
BMC Cancer
; 15: 374, 2015 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-25952930
10.
Prolonged disease stability with trabectedin in a heavily pretreated elderly patient with metastatic leiomyosarcoma of the thigh and renal failure: a case report and review of the literature.
Oncol Res
; 20(10): 483-90, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24308159
11.
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination.
Front Oncol
; 12: 844250, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36110934
12.
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.
BMC Cancer
; 11: 31, 2011 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21266046
13.
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
Cells
; 10(11)2021 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34831119
14.
Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity in vivo.
Mol Cancer Ther
; 20(6): 1039-1051, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33785653
15.
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study.
Cancers (Basel)
; 13(24)2021 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34944915
16.
Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor Cells.
Cancers (Basel)
; 13(13)2021 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34209309
17.
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.
BMC Cancer
; 10: 631, 2010 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-21087480
18.
Delving into PARP inhibition from bench to bedside and back.
Pharmacol Ther
; 206: 107446, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31756364
19.
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series.
Cells
; 9(11)2020 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33142760
20.
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.
Clin Cancer Res
; 26(23): 6321-6334, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32900797